Hyperinsulinemia, an overlooked clue, and potential way forward in metabolic dysfunction-associated steatotic liver disease
SA Harrison, J Dubourg, M Knott, J Colca - Hepatology, 2023 - journals.lww.com
Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with
other features of the metabolic syndrome such as type 2 diabetes. The progression of the …
other features of the metabolic syndrome such as type 2 diabetes. The progression of the …
Envisioning how to advance the MASH field
AM Allen, ZM Younossi, AM Diehl… - Nature Reviews …, 2024 - nature.com
Since 1980, the cumulative effort of scientists and health-care stakeholders has advanced
the prerequisites to address metabolic dysfunction-associated steatotic liver disease …
the prerequisites to address metabolic dysfunction-associated steatotic liver disease …
[HTML][HTML] Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASH
Nonalcoholic steatohepatitis (NASH) is the most common chronic liver disease globally and
a leading cause for liver transplantation in the US. Its pathogenesis remains imprecisely …
a leading cause for liver transplantation in the US. Its pathogenesis remains imprecisely …
Clinical trial: effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy‐confirmed nonalcoholic steatohepatitis
Background An approved therapy for nonalcoholic steatohepatitis (NASH) and fibrosis
remains a major unmet medical need. Aim To investigate the histological and metabolic …
remains a major unmet medical need. Aim To investigate the histological and metabolic …
[HTML][HTML] NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review
CM Sergi - International Journal of Molecular Sciences, 2024 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD), or metabolic dysfunction-associated steatotic liver
disease (MASLD), is a liver condition that is linked to overweight, obesity, diabetes mellitus …
disease (MASLD), is a liver condition that is linked to overweight, obesity, diabetes mellitus …
Liver Biopsy Evaluation in MASH Drug Development: Think Thrice, Act Wise
SA Harrison, J Dubourg - Journal of Hepatology, 2024 - Elsevier
With an estimated global prevalence of 30%, the most common chronic liver disease namely
metabolic dysfunction-associated steatotic liver disease (MASLD) is closely entangled with …
metabolic dysfunction-associated steatotic liver disease (MASLD) is closely entangled with …
[引用][C] Augmented liver pathology: Artificial intelligence and the assessment of hepatocellular neoplasms
AD Burt - Histopathology, 2023 - pubmed.ncbi.nlm.nih.gov